Adjuvant interferon alpha-2b in Chinese patients with high-risk acral malignant melanoma

Trial Profile

Adjuvant interferon alpha-2b in Chinese patients with high-risk acral malignant melanoma

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jun 2011

At a glance

  • Drugs Interferon alpha-2b; Interferon alpha-2b
  • Indications Malignant melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2011 Preliminary results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
    • 07 May 2011 New trial record
    • 12 Apr 2011 Results published in the European Journal of Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top